Literature DB >> 20493421

Obstructive sleep apnoea syndrome and the metabolic syndrome in an internal medicine setting.

Francesco Angelico1, Maria del Ben, Teresa Augelletti, Rosanna de Vita, Rocco Roma, Francesco Violi, Mario Fabiani.   

Abstract

BACKGROUND: Obstructive sleep apnoea syndrome (OSAS) is widely accepted as a cardiovascular risk factor. Lately it has been considered in turn as both a component and one of the causes of the metabolic syndrome (MS).
METHODS: We studied 281 heavy snorers of both sexes consecutively attending a metabolic clinic. Aim was to evaluate the association of OSAS and MS in a large series of patients within an internal medicine setting. Patients underwent a clinical and biochemical work up and performed unattended polysomnography.
RESULTS: Of 226 non-diabetic snorers, 48 had primary snoring; 54 mild, 51 moderate, and 73 severe OSAS. A positive association was found between OSAS severity, central obesity indices and the mean metabolic score (p=0.016). Prevalence of hypertension increased with OSA severity (p=0.010). Polysomnographic indices were correlated with the metabolic score, insulin levels and central obesity indices. At regression analysis, male sex (t=3.92; p=0.000) and waist circumference (t=3.93; p=0.000) were independently associated with AHI (apnoea/hypopnoea index), while ODI (oxygen desaturation index) and waist circumference were the independent predictors (t=2.16; p=0.033 and t=3.74; p=0.000 respectively) of the metabolic score. Prevalence of OSA was 83% in 55 patients with diabetes and 34% had severe OSA. Almost all diabetics with OSA had MS. The metabolic score was higher in diabetic OSA as compared to non-diabetic OSAS (p=0.000).
CONCLUSIONS: Our findings show a high prevalence of OSAS among patients referred to a metabolic outpatient clinic because of suspected metabolic disorders and heavy snoring and suggest a strong bidirectional association between OSAS and MS. Copyright 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20493421     DOI: 10.1016/j.ejim.2010.03.006

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  20 in total

1.  Socio-demographic characteristics, health behaviour, co-morbidity and accidents in snorers: a population survey.

Authors:  Peter Torzsa; Andras Keszei; Laszlo Kalabay; Eszter Panna Vamos; Rezso Zoller; Istvan Mucsi; Marta Novak; Maria S Kopp
Journal:  Sleep Breath       Date:  2010-11-14       Impact factor: 2.816

2.  Comparison of metabolic syndrome with growing epidemic syndrome Z in terms of risk factors and gender differences.

Authors:  Meral Uyar; Vedat Davutoğlu; Neriman Aydın; Ayten Filiz
Journal:  Sleep Breath       Date:  2012-06-23       Impact factor: 2.816

3.  Assessment of the performance of nasal pillows at high CPAP pressures.

Authors:  Xueling Zhu; Alison J Wimms; Adam V Benjafield
Journal:  J Clin Sleep Med       Date:  2013-09-15       Impact factor: 4.062

4.  Strong interplay between metabolic syndrome, obstructive sleep apnoea, oxidative stress and arterial dysfunction.

Authors:  Maria Del Ben; Lorenzo Loffredo; Francesco Violi; Francesco Angelico
Journal:  Sleep Breath       Date:  2013-08-01       Impact factor: 2.816

5.  Amelioration of obstructive sleep apnea in REM sleep behavior disorder: implications for the neuromuscular control of OSA.

Authors:  Jixiong Huang; Jihui Zhang; Siu Ping Lam; Shirley Xin Li; Crover Kwok Wah Ho; Venny Lam; Mandy Wai Man Yu; Yun-Kwok Wing
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

6.  Positive airway pressure therapy for sleep-disordered breathing confers short-term benefits to patients with spinal cord injury despite widely ranging patterns of use.

Authors:  Jeanette P Brown; Kristy A Bauman; Armando Kurili; Gianna M Rodriguez; Anthony E Chiodo; Robert G Sitrin; Helena M Schotland
Journal:  Spinal Cord       Date:  2018-03-07       Impact factor: 2.772

7.  Obstructive sleep apnea and the metabolic syndrome in an elderly healthy population: the SYNAPSE cohort.

Authors:  Hourfil-Gabin Ntougou Assoumou; Jean-Michel Gaspoz; Emilia Sforza; Vincent Pichot; Sébastien Celle; Delphine Maudoux; Michel Kossovsky; Florian Chouchou; Jean-Claude Barthelemy; Frédéric Roche
Journal:  Sleep Breath       Date:  2011-09-18       Impact factor: 2.816

8.  Sleep architecture and obstructive sleep apnea in obese children with and without metabolic syndrome: a case control study.

Authors:  Shabnam Jalilolghadr; Zohreh Yazdi; Manoochehr Mahram; Farkhondeh Babaei; Neda Esmailzadehha; Hoormehr Nozari; Fatemeh Saffari
Journal:  Sleep Breath       Date:  2015-12-28       Impact factor: 2.816

9.  The effect of nightly nasal CPAP treatment on nocturnal hypoxemia and sleep disorders in mustard gas-injured patients.

Authors:  Ensieh Vahedi; Ali Reza Fazeli Varzaneh; Mostafa Ghanei; Shahla Afsharpaiman; Zohre Poursaleh
Journal:  Sleep Breath       Date:  2014-01-16       Impact factor: 2.816

10.  Numerical simulation for the upper airway flow characteristics of Chinese patients with OSAHS using CFD models.

Authors:  Jie Tan; Jianmin Huang; Jianguo Yang; Desheng Wang; Jianzhi Liu; Jingbo Liu; Shuchun Lin; Chen Li; Haichun Lai; Hongyu Zhu; Xiaohua Hu; Dongxu Chen; Longxiang Zheng
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-03       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.